Back to investors
OCTAGON CAPITAL ADVISORS LP
OCTAGON CAPITAL ADVISORS LP
Latest filing: 2026-06-30
OCTAGON CAPITAL ADVISORS LP runs OCTAGON CAPITAL ADVISORS LP and currently holds 27 stock positions, which is fewer than the average of 230 among the investors we track. The portfolio is valued at approximately $1.11B. Their top holdings are DNTH, DFTX, ABVX, COGT, ALMS. The top five represent 55.8% of reported portfolio weight. OCTAGON CAPITAL ADVISORS LP ranks #N/A out of 1000 investors tracked by Alpha Score. In the most recent quarter, OCTAGON CAPITAL ADVISORS LP initiated 2 new positions. They added to 3 existing positions. They trimmed 4 positions. Their current best-performing preview position is DFTX with returns of +148.89%.
Sign in to enable email alerts for this investor.
Showper page
27 stock holdings
| Holding | Weight | Avg Buy | Current | Return | Quarter Change |
|---|---|---|---|---|---|
 DNTH DIANTHUS THERAPEUTICS INC | 16.14% | $23.81 | $111.10 | +366.61% | Trimmed -5.39% |
 DFTX DEFINIUM THERAPEUTICS INC | 12.47% | $23.76 | $44.91 | +89.02% | Added +20.90% |
 ABVX ABIVAX SA | 11.89% | $49.04 | $114.95 | +134.40% | Added +46.68% |
 COGT COGENT BIOSCIENCES INC | 8.17% | $9.42 | $36.73 | +289.92% | Held |
 ALMS ALUMIS INC | 7.16% | $11.06 | $24.17 | +118.54% | Held |
 AVBP ARRIVENT BIOPHARMA INC | 6.15% | $19.07 | $29.12 | +52.70% | Held |
 BIOA BIOAGE LABS INC | 3.85% | $13.60 | $9.48 | -30.29% | Held |
 MIRM MIRUM PHARMACEUTICALS INC | 3.57% | $92.38 | $96.31 | +4.25% | Held |
 KYMR KYMERA THERAPEUTICS INC | 3.20% | $57.09 | $119.80 | +109.84% | Trimmed -27.06% |
 AKTS AKTIS ONCOLOGY INC | 2.78% | $17.89 | $24.07 | +34.54% | Held |
Showing 1-10 of 27